Cargando…
Author Correction: FGL2 promotes tumor progression in the CNS by suppressing CD103(+) dendritic cell differentiation
Autores principales: | Yan, Jun, Zhao, Qingnan, Gabrusiewicz, Konrad, Kong, Ling-Yuan, Xia, Xueqing, Wang, Jian, Ott, Martina, Xu, Jingda, Davis, R. Eric, Huo, Longfei, Rao, Ganesh, Sun, Shao-Cong, Watowich, Stephanie S., Heimberger, Amy B., Li, Shulin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6377651/ https://www.ncbi.nlm.nih.gov/pubmed/30770835 http://dx.doi.org/10.1038/s41467-019-08770-5 |
Ejemplares similares
-
FGL2 promotes tumor progression in the CNS by suppressing CD103(+) dendritic cell differentiation
por: Yan, Jun, et al.
Publicado: (2019) -
Author Index for Volume 103
Publicado: (2010) -
FGL2-targeting T cells exhibit antitumor effects on glioblastoma and recruit tumor-specific brain-resident memory T cells
por: Zhao, Qingnan, et al.
Publicado: (2023) -
Author Correction: Pivotal role of CD103 in the development of psoriasiform dermatitis
por: Fukui, Takehito, et al.
Publicado: (2020) -
Discovery of cell surface vimentin targeting mAb for direct disruption of GBM tumor initiating cells
por: Noh, Hyangsoon, et al.
Publicado: (2016)